Abstract:Background: Immunosuppressive cell interactions are responsible for tumor progression and metastasis, as well as anti-tumor immune dysfunction. However, the communication pattern remains unclear. Methods: We first integrated two single-cell RNA-seq datasets (GSE72056 and GSE103322) of different tumor types to increase the diversity of immunosuppressive cells. Then, based on the analysis results of the communication network, gene regulatory network (GRN), and highly activated pathways, we identified the hub gene in the immunosuppressive tumor microenvironment (TME). To further explore the molecular features of the identified gene, we performed several in silico analysis and in vitro experiments including qRT-PCR and CCK-8 assay. Results: Four types of immunosuppressive cells were identified, including cancer-associated fibroblasts (CAFs), tumor-associated macrophages (TAMs), tumor-associated neutrophils (TANs), and regulatory T cells (Tregs). Based on GRNs and the interactions of immunosuppressive cells and tumor cells, we constructed an intercellular communication signature that divided the pan-cancer TME into two clusters with distinct immunological features and different responses to immunotherapy. In combination with pathway analysis, JunB proto-oncogene (JUNB) was identified as the hub gene of the immunosuppressive TME, and it designed a non-inflamed TME of bladder cancer according to evidence that JUNB was negatively correlated with immunomodulators, chemokines, major histocompatibility complex molecules, immune cell infiltration abundances, anti-cancer immune response, and immune checkpoint inhibitors. Moreover, JUNB may predict an unfavorable response to immunotherapy. The signaling network of the four types of cells demonstrated the dominant roles of CAFs and TAMs in the TME. Further investigation uncovered that the complement signal was highly activated in the interactions between subpopulations of the inflammatory phenotype of CAFs and TAMs. Functional experiment results demonstrated the upregulated JUNB in bladder cancer tissues and low-immunity-score tissues. In addition, CAFs showed a pro-tumor proliferation effect via JUNB. Conclusion: Our findings gave insights into the immunosuppressive TME communication network and provided potential therapeutic targets.

JunB: a paradigm for Jun family in immune response and cancer

[Dual Role of Transcription Factor AP-2 in Carcinogenesis].

Dissecting Immunosuppressive Cell Communication Patterns Reveals JunB Proto-Oncogene (JUNB) Shaping a Non-Inflamed Tumor Microenvironment

Comprehensive Pancancer Analysis of TUBB6 as a Marker for Prognosis and Immunotherapy Response

The AP-1 transcription factor JunB is essential for multiple myeloma cell proliferation and drug resistance in the bone marrow microenvironment

A Study of JUN’s Promoter Region and Its Regulators in Chickens

C-Jun, a Crucial Molecule in Metastasis of Breast Cancer and Potential Target for Biotherapy.

AP-1 subunits: quarrel and harmony among siblings

The transcription factor c-JUN/AP-1 promotes HBV-related liver tumorigenesis in mice

Integrative epigenomic and transcriptomic analysis reveals the requirement of JUNB for hematopoietic fate induction

Nuclear JAK2: Form and Function in Cancer

JUN mediates the senescence associated secretory phenotype and immune cell recruitment to prevent prostate cancer progression

JunB is required for CD8+ T cell responses to acute infections

Critical Role of C-Jun Overexpression in Liver Metastasis of Human Breast Cancer Xenograft Model

B cell function in patients with systemic lupus erythematosus is regulated by the upregulation of JunD

Role of the Epigenetic Modifier JMJD6 in Tumor Development and Regulation of Immune Response

A non-canonical repressor function of JUN restrains YAP activity and liver cancer growth

Regulation of alphabeta/gammadelta T cell development by the activator protein 1 transcription factor c-Jun.

The potential of activator protein 1 (AP-1) in cancer targeted therapy

JUNB Governs a Feed-Forward Network of TGFβ Signaling That Aggravates Breast Cancer Invasion

JNK-Dependent cJun Phosphorylation Mitigates TGFβ- and EGF-Induced Pre-Malignant Breast Cancer Cell Invasion by Suppressing AP-1-Mediated Transcriptional Responses.